BCAX
Bicara Therapeutics Inc.
16.60$
-4.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +600.0% | -7.1% | +0.0% | +15.4% | +0.0% | +26.7% | +0.0% | +26.3% | +1,200.0% | -85.9% | +0.0% | – | |
| – | +47.4% | +49.9% | -9.5% | +95.7% | +56.6% | +8.5% | +1.2% | +3.5% | +23.1% | +31.7% | +40.6% | – | |
| – | – | -212.2% | – | -161.4% | – | – | -137.6% | – | +166.9% | +44.4% | +16.2% | – | |
| – | +190.7% | -99.1% | +375.0% | -57.9% | +400.0% | -100.0% | – | – | +466.7% | -74.8% | +0.0% | – | |
| – | +190.7% | – | -132.8% | -57.9% | +400.0% | – | – | – | -65.1% | – | -283.3% | – | |
| – | +388.0% | -99.9% | +435.8% | +45,422.5% | -100.3% | – | -70.7% | +223.0% | +7,062.8% | +423.0% | -98.6% | – | |
| – | +537.3% | -107.7% | – | – | -109.8% | – | – | – | – | – | -200.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.